Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Antonelli

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|December 4, 2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liverStefano Fiorucci, Elisabetta Antonelli, Vincenzo Brancaleone, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2005
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channelsEleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in miceStefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, et al.
British Journal of Pharmacology|February 9, 2002
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathwayStefano Fiorucci, Elisabetta Antonelli, Andrea Mencarelli, et al.
Journal of Personalized Medicine|April 25, 2025
Non-Adherence Rate to Oral Mesalamine in Ulcerative Colitis Patients: A Systematic Review with Meta-AnalysisCristiano Pagnini, Elisabetta Antonelli, Barbara Scrivo, et al.
Annals of Diagnostic Pathology|November 3, 2018
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel diseaseVincenzo Villanacci, Moris Cadei, Francesco Lanzarotto, et al.
Gastroenterology|October 19, 2005
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugsStefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 26, 2017
Eosinophilia - associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel diseaseGabriella Canavese, Vincenzo Villanacci, Elisabetta Antonelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2005
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasisStefano Fiorucci, Carlo Clerici, Elisabetta Antonelli, et al.
European Journal of Gastroenterology & Hepatology|June 26, 2025
Adherence to clinical and endoscopic standards of quality in inflammatory bowel disease: a nationwide survey from the Italian Association of Hospital Gastroenterologists and EndoscopistsMaria Carla Di Paolo, Andrea Cassinotti, Cristiano Pagnini, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|December 4, 2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liverStefano Fiorucci, Elisabetta Antonelli, Vincenzo Brancaleone, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2005
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channelsEleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in miceStefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, et al.
British Journal of Pharmacology|February 9, 2002
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathwayStefano Fiorucci, Elisabetta Antonelli, Andrea Mencarelli, et al.
Journal of Personalized Medicine|April 25, 2025
Non-Adherence Rate to Oral Mesalamine in Ulcerative Colitis Patients: A Systematic Review with Meta-AnalysisCristiano Pagnini, Elisabetta Antonelli, Barbara Scrivo, et al.
Annals of Diagnostic Pathology|November 3, 2018
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel diseaseVincenzo Villanacci, Moris Cadei, Francesco Lanzarotto, et al.
Gastroenterology|October 19, 2005
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugsStefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 26, 2017
Eosinophilia - associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel diseaseGabriella Canavese, Vincenzo Villanacci, Elisabetta Antonelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2005
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasisStefano Fiorucci, Carlo Clerici, Elisabetta Antonelli, et al.
European Journal of Gastroenterology & Hepatology|June 26, 2025
Adherence to clinical and endoscopic standards of quality in inflammatory bowel disease: a nationwide survey from the Italian Association of Hospital Gastroenterologists and EndoscopistsMaria Carla Di Paolo, Andrea Cassinotti, Cristiano Pagnini, et al.
Pageof 7